S 141 · 117th Congress 2021โ€“2023, ended

End Taxpayer Subsidies for Drug Ads Act

Latest action · Jan 28, 2021 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 28, 2021
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

End Taxpayer Subsidies for Drug Ads Act

This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.

Cosponsors 22

Members who signed on, in the order they did. Signatures ran from Jan 28, 2021 to Mar 11, 2021; 20 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MNAmy KlobucharOriginalJan 28, 2021
I-MEAngus S. King Jr.OriginalJan 28, 2021
I-VTBernard SandersOriginalJan 28, 2021
D-MDChris Van HollenOriginalJan 28, 2021
D-CADianne FeinsteinOriginalJan 28, 2021
D-MAElizabeth WarrenOriginalJan 28, 2021
D-RIJack ReedOriginalJan 28, 2021
D-WVJoe Manchin IIIOriginalJan 28, 2021
D-NYKirsten E. GillibrandOriginalJan 28, 2021
D-NHMargaret Wood HassanOriginalJan 28, 2021
D-HIMazie K. HironoOriginalJan 28, 2021
D-COMichael F. BennetOriginalJan 28, 2021
D-VTPatrick J. LeahyOriginalJan 28, 2021
D-CTRichard BlumenthalOriginalJan 28, 2021
D-ILRichard J. DurbinOriginalJan 28, 2021
D-RISheldon WhitehouseOriginalJan 28, 2021
D-OHSherrod BrownOriginalJan 28, 2021
D-WITammy BaldwinOriginalJan 28, 2021
D-VATim KaineOriginalJan 28, 2021
D-MNTina SmithOriginalJan 28, 2021
D-HIBrian SchatzFeb 23, 2021
D-CTChristopher MurphyMar 11, 2021

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Jan 28, 2021

Actions 2

Everything that happened, newest first.

  1. Jan 28, 2021Introduced in Senate
  2. Jan 28, 2021Read twice and referred to the Committee on Finance.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 117-809PRESCRIPTION DRUG PRICE INFLATION: AN URGENT NEED TO LOWER DRUG PRICES IN MEDICARE224 pagesFinance CommitteeMar 16, 2022

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
IN11951Proposals to Deny a Federal Tax Deduction for Prescription Drug Advertising Expenses ArchivedInsightJun 10, 2022

Related bills 4

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 73End Taxpayer Subsidies for Drug Ads ActReintroduction ofJan 10, 2019
S 1898Affordable Medications ActRelated billMay 27, 2021
S 4691No Tax Breaks for Drug Ads ActReintroduced BillJul 11, 2024
HR 6392No Tax Breaks for Drug Ads ActRelated billJan 13, 2022

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
Short Title(s) as Introduced
End Taxpayer Subsidies for Drug Ads Act

Subjects

Assigned by the Library of Congress. Policy area: Taxation.

Text 1

Each version as it was printed, newest first.

  1. Jan 28, 2021Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.